The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery

Trial Profile

The effect of levosimendan, on renal blood flow, function and oxygen uptake during acute renal failure after cardiac surgery

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Oct 2017

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Renal failure; Renal impairment
  • Focus Pharmacodynamics
  • Acronyms Levo-AKI; LEVOAKI
  • Most Recent Events

    • 03 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 03 Oct 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
    • 28 Nov 2015 New source identified and integrated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top